Market Place
Sourcing Support
Bioxodes Secures €5.5M For Stroke Candidate Trial Prep
10 Dec 2025 //
GLOBENEWSWIRE
Bioxodes Unveils BIOX-101 Data, Revealing Stroke Breakthrough
14 Nov 2025 //
GLOBENEWSWIRE
Bioxodes Appoints Philippe Monteyne Chair To Drive Stroke Program
07 Oct 2025 //
GLOBENEWSWIRE
Bioxodes Ph2a Stroke Data Reveals BIOX-101 Breakthrough Potential
11 Sep 2025 //
GLOBENEWSWIRE
Bioxodes halts phase 2 stroke trial after interim review success
24 Apr 2025 //
FIERCE BIOTECH
Bioxodes Gets Orphan Drug Nod For Hemorrhagic Stroke Therapy
05 Mar 2025 //
GLOBENEWSWIRE
Bioxodes Secures Funding To Reach 2025 Milestones & Series B
12 Feb 2025 //
GLOBENEWSWIRE
Bioxodes meets enrollment milestone in Phase 2a trial
19 Dec 2024 //
GLOBENEWSWIRE
Bioxodes Reports Positive DMC Meeting For BIOX-101 Phase 2a Trial
21 Aug 2024 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.